Shire plc (ADR) (NASDAQ:SHPG)

Pills

AbbVie Earnings Take Back Seat to Shire Merger

AbbVie Inc. (NYSE: ABBV) reported second-quarter 2014 results before markets opened Friday. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.82 on revenues of $4.93 billion. ...
Read Full Story »
Pills

Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates

The specialty pharmaceutical sector is exploding with news of takeovers, exchanges and possible mergers. The biggest is the possible deal between activist hedge fund manager Bill Ackman's Pershing Square, Valeant ...
Read Full Story »
Samuel Beckett Bridge

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

St. Patrick's Day may have come and gone for this year, but some of the biotechnology stocks that are domiciled in Ireland might just be getting ready for the party. ...
Read Full Story »
investor research

Top Analyst Upgrades and Downgrades: eBay, NBG, Petrobras, Twitter and More

Stocks have had gains for eight weeks now and the stock market keeps challenging all-time highs. It is time for investors to start positioning their assets and portfolios for 2014. ...
Read Full Story »
Pills

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

The wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company ViroPharma (NASDAQ: ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Ariad, Hecla, HP, Micron and More

Earnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: CIT, Intel, Nike, J.C.Penney and More

As a government shutdown and debt ceiling debate rage on as new (or repetitive) market risks, investors have to decide which stocks to buy and which to sell or avoid. ...
Read Full Story »
pills

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Typically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that target rare or hard to treat diseases as orphan drug ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Invesco, Prudential, Shire and More

Investors often get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors frequently do not get to see is when those same analysts issue downgrades or when ...
Read Full Story »
Bull and Bear

Top Analyst Downgrades and Stocks to Sell: Dean Foods, Dendreon, Mylan and More

Investors frequently see analyst upgrades and Buy ratings from Wall Street research calls, but they often do not get to see the so-called Sell ratings. 24/7 Wall St. reviews many ...
Read Full Story »
Bull and Bear

Eleven Must-Read Weekend Stock Stories for Monday

24/7 Wall St. has tracked many stocks on the move in the last week. Now it is the weekend and this can be considered your weekend cheat sheet for the ...
Read Full Story »
rumors

Pharma Merger/Buyout Hunt Continues in Biotech, Valuations Under Focus

The hunt by Big Pharma stocks for smaller drug companies and biotech stocks continues. A report citing "sources" from Dow Jones News has signaled that Bristol-Myers Squibb (NYSE: BMY) has ...
Read Full Story »